Themis Medicare Ltd logo

Themis Medicare Ltd

NSE: THEMISMED BSE: 530199

₹100.90

-1.16 (1.14%)

Sun, 22 Nov 2026, 05:13 pm

mtf coin illustrationMTF 5xInvest in Themis Medicare Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)934.82
PE Ratio23.28
Dividend0.49
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Themis Medicare Share Price Live Chart

1 Day

-1.16 (1.14%)

No Result Found

Summary

  • Market Cap (in Cr)

    876.61

  • Net Profit (in Cr)

    1.14

  • P/B

    1.66

  • Sector P/E

    40.30

  • P/E

    548.92

  • EV/EBITDA

    30.41

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    10.63

  • ROCE (Industry)

    7.84

  • RONW (Industry)

    6.60

  • ROE

    0.45

  • ROCE

    2.92

  • Debt/Equity

    0.25

  • EPS (TTM)

    0

  • Dividend Yield

    0.53

  • Book Value

    42.64

  • Interest Cover

    1.26

Analysis

all

thumbs up icon

Pros

  • Dividends paid are thoroughly covered by earnings (15.4x coverage).
  • Themis Medicare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Themis Medicare is profitable, therefore cash runway is not a concern.
  • Debt is covered by short term assets, assets are 2x debt.
thumbs up icon

Cons

  • Dividends per share have fallen over the past 10 years.
  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Themis Medicare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Themis Medicare's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Debt is not well covered by operating cash flow (0.4%, less than 20% of total debt).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters67.1167.1167.1167.1167.15
FII0.010.010.110.050.06
DII0.010.010.010.010.01
Public32.8732.8732.7832.8332.78
Government00000

Read More

Technical Analysis

RSI

37.31

MACD

-2.58

50 DMA

107.82

200 DMA

101.55

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic158.80129.68112.25100.5683.1371.4442.32
Fibonacci129.68118.55111.68100.5689.4382.5671.44
Camarilla102.84100.1797.50100.5692.1689.4986.82

Pivots Level: Classic

R3

+58.24

158.80

R2

+29.12

129.68

R1

+11.70

112.25

100.56
100.56
Pivot Point
LTP: 94.87

S1

-17.42

83.13

S2

-29.12

71.44

S3

-58.24

42.32

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    97.67

  • 20-EMA

    99.37

  • 30-EMA

    101.36

  • 50-EMA

    104.44

  • 100-EMA

    106.61

  • 200-EMA

    108.35

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
14 Nov 2026board-meetingsQuarterly Results
05 Nov 2026board-meetingsQuarterly Results
08 Sept 2026agm
28 May 2026dividend₹0.50 Dividend /Share23 Sept 2026
13 Feb 2026board-meetingsQuarterly Results
13 Nov 2025board-meetingsQuarterly Results
19 Aug 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 0.505 Sept 2025
04 Aug 2025dividendDividend - Re 0.50 Per Share05 Sept 2025
20 May 2025dividend₹0.50 Dividend /Share05 Sept 2025

Read More

Peer Comparison

Themis Medicare Ltd logo

Themis Medicare Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Themis Medicare Ltd About

Themis Medicare is engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1969

Headquarters

CEO

Dinesh S Patel

Employees

Contact

Website icon

Website

http://www.themismedicare.com

Email icon

Email

sangameshwar.iyer@themismedicare.com; cfoassist@th

Phone icon

Phone

91-260-2421675

Location icon

Location

Plot No 69 A GIDC Indl Estate, Vapi, Valsad, Gujarat, 396195

Read More

Themis Medicare Ltd Company History

YearHistory
2011
  • Themis Medicare introduced a 'calcium' preparation with fruity gummies for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare introduced a 'Multivitamin' for pediatric use under the brand name 'THEMIBEAR'.
  • Themis Medicare launched the brand LUMIXYL, entering the COSMETO-DERMATOLOGY segment.
2013
  • Themis Medicare Limited entered into a License and Supply Agreement with Novartis India Limited to supply Diclofenac topical gel.
  • Themis Medicare Ltd entered into a Supply & Distribution Agreement with Novartis India Ltd to supply Diclofenac Sodium 75mg per ml Injection.
2014
  • Themis invented Aquadol Spass 1ml Injection and commenced production, marketing, and sales.
2022
  • Inosine Pranobex, a unique Immunomodulator drug, received use approval from The Drug Controller General of India for the treatment of COVID-19.
2023
  • The Company has split its face value from Rs. 10/- to Rs. 1/-.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkBuy659356141.3209 Oct 2025
GRAVITON RESEARCH CAPITAL LLPbulkSell659356141.6309 Oct 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy685949141.6109 Oct 2025
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell685949141.7209 Oct 2025
TEJAS TRADEFIN LLPbulkBuy72009735.7602 Jun 2021
ANUJ ANANTRAI SHETHbulkBuy11250060.2512 Mar 2013
GAGANDEEP CREDIT CAPITAL PRIVATE LIMITEDbulkSell11250060.2512 Mar 2013
THEMIS DISTRIBUTORS PVT. LTD.bulkBuy234612181.526 Mar 2010
KISHORCHAND RATULSIDAS LAKDAWALAbulkSell235712181.526 Mar 2010
KISHOR CHANDRA TULSIDAS LAKDAWALAbulkSell8997617504 Mar 2010

Read More

Themis Medicare Ltd News

Themis Medicare Q2FY27: EBITDA turns positive

Themis Medicare reported a return to operating profitability in Q2FY27 with EBITDA of ₹5.58 crore. Revenue grew 15.1% YoY to ₹89.74 crore, driven by a 71% rebound in API business.

15 Nov 2026

companies

Themis Medicare board meet moved to Nov 14

Themis Medicare rescheduled its board meeting to November 14, 2026, to approve Q2FY27 results. The trading window remains closed for designated persons.

02 Nov 2026

companies

Themis Medicare promoter pledges 15 lakh shares

Vividhmargi Investments pledged 15,00,000 equity shares of Themis Medicare Ltd to CTL Trusteeship Limited on October 22, 2026, for personal borrowing.

24 Oct 2026

companies

Themis Medicare seeks shareholder approval for director re-appointment

Themis Medicare Limited has issued a postal ballot notice for the re-appointment of Bhaskar Vemban Iyer as Independent Director. E-voting opens October 24, 2026.

23 Oct 2026

companies

Themis Medicare holds 56th AGM; adopts FY26 results

Themis Medicare Limited concluded its 56th Annual General Meeting on September 30, 2026. Shareholders adopted standalone and consolidated financial statements for FY26 and approved the re-appointment of Mr. Rajneesh Anand.

30 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Themis Medicare Ltd?

    As of 22/11/2026 at 10:43 PM, Themis Medicare Ltd shares are trading at ₹100.90.

  • 2.What is the market cap. of Themis Medicare Ltd?

    As of 22/11/2026, the market capitalization of Themis Medicare Ltd is ₹934.82 crore.

  • 3.When was Themis Medicare Ltd founded?

    Themis Medicare Ltd was founded in 1969.

  • 4.What are the P/E and P/B ratios of Themis Medicare Ltd?

    As of 22/11/2026, Themis Medicare Ltd has a P/E ratio of 23.28 and a P/B ratio of 1.66.

  • 5.How can I buy shares of Themis Medicare Ltd?

    You can buy shares of Themis Medicare Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Themis Medicare Ltd?

    As of September,2026, promoters hold 67.11% in Themis Medicare Ltd, while FIIs, DIIs and public shareholders hold 0.01%, 0.01% and 32.87%, respectively.

  • 7.Does Themis Medicare Ltd pay dividends?

    Yes, Themis Medicare Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.50 Dividend /Share per share.

  • 8.What is the dividend yield of Themis Medicare Ltd?

    As of 22 November, 2026, the dividend yield of Themis Medicare Ltd stands at 0.49%.

  • 9.What are the latest financial results of Themis Medicare Ltd?

    For the financial year ended March 2025, Themis Medicare Ltd reported revenue of ₹406.00 crore and a net profit of ₹29.83 crore.

  • 10.What is the Stock symbol of Themis Medicare Ltd?

    THEMISMED is the stock symbol of Themis Medicare Ltd.

  • 11.Who is the CEO of Themis Medicare Ltd?

    The CEO of Themis Medicare Ltd is Dinesh S Patel.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconthemis medicare ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800